View:
Download DOC
Download PDF
Download XLS
SEC FORM 3/A SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
TEISSEYRE THOMAS
(Last) (First) (Middle)
C/O HYPERFINE, INC.
351 NEW WHITFIELD STREET
(Street)
GUILFORD CT 06437
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/24/2023 		3. Issuer Name and Ticker or Trading Symbol
Hyperfine, Inc. [ HYPR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
07/24/2023
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 105,196(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (2) 02/09/2032 Class A Common Stock 150,000 0.91 D
Stock Option (right to buy) (3) 02/09/2032 Class A Common Stock 62,500 0.91 D
Stock Option (right to buy) (4) 04/28/2032 Class A Common Stock 37,500 0.91 D
Stock Option (right to buy) (5) 12/20/2032 Class A Common Stock 400,000 0.761 D
Explanation of Responses:
1. Represents 33,321 shares of Class A common stock and 71,875 restricted stock units.
2. These options were granted on February 9, 2022. 25% of the options vested on January 30, 2023 and the remaining 75% vest in 36 successive equal monthly installments thereafter, in each case, subject to continued service through the applicable vesting date.
3. These options were granted on February 9, 2022. 25% of the options vested on February 9, 2023 and the remaining 75% vest in 36 successive equal monthly installments thereafter, in each case, subject to continued service through the applicable vesting date.
4. These options were granted on April 28, 2022. 25% of the options vested on April 28, 2023 and the remaining 75% vest in 36 successive equal monthly installments thereafter, in each case, subject to continued service through the applicable vesting date.
5. These options were granted on December 20, 2022. 25% of the options vest on December 16, 2023 and the remaining 75% vest in 36 successive equal monthly installments thereafter, in each case, subject to continued service through the applicable vesting date.
Remarks:
This amended Form 3 is being filed to correct the number of shares in Table I, Column 2.
/s/ Brett Hale, Attorney-in-Fact 11/20/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY


            Know all by these presents, that the undersigned hereby constitutes
and appoints Maria Sainz and Brett Hale, each of Hyperfine, Inc., and Michael
Fantozzi, John Condon,Samantha Silver, Meg Green, and Brenda Meyette, each of
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., signing singly,
with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:

            (1)   execute for and on behalf of the undersigned, forms and
                  authentication documents for EDGAR Filing Access;

            (2)   do and perform any and all acts for and on behalf of the
                  undersigned that may be necessary or desirable to complete and
                  execute any such forms and authentication documents;

            (3)   execute for and on behalf of the undersigned, in the
                  undersigned's capacity as an officer, director and/or 10%
                  shareholder of Hyperfine, Inc. (the "Company"), Forms 3, 4 and
                  5 in accordance with Section 16(a) of the Securities Exchange
                  Act of 1934, as amended, and the rules thereunder;

            (4)   do and perform any and all acts for and on behalf of the
                  undersigned that may be necessary or desirable to complete
                  and execute any such Form 3, 4 or 5 and timely file such form
                  with the United States Securities and Exchange Commission and
                  any stock exchange or similar authority; and

            (5)   take any other action of any type whatsoever in connection
                  with the foregoing that, in the opinion of such
                  attorney-in-fact, may be of benefit to, in the best interest
                  of, or legally required by the undersigned, it being
                  understood that the documents executed by such
                  attorney-in-fact on behalf of the undersigned pursuant to this
                  Power of Attorney shall be in such form and shall contain such
                  terms and conditions as such attorney-in-fact may approve in
                  such attorney-in-fact's discretion.

            The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

            This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

            IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed this 10th day of July 2023.






                                         /s/ Thomas Teisseyre
                                         ---------------------------------
                                         Signature


                                         Thomas Teisseyre
                                         ---------------------------------
                                         Print Name